Cancer Treatments Using mRNA Technology Targeted as COVID Shots Sales Decline
BioNTech SE and Moderna, Inc., two leading pharmaceutical companies that developed the mRNA COVID-19 biological, are facing new financial and regulatory challenges as demand for COVID booster shots continues to fall and U.S. health policy changes reshape the vaccine market.1 Moderna cut its 2025 sales forecast to between $1.5 billion and $2.2 billion, down as […]